Company intelligence / Profile preview

Mint Pharmaceuticals

Mississauga, Ontario, Canadamintpharma.com ↗

Ownership: Private
Employees: ~92
Development stage: Other

Overview

Mint Pharmaceuticals is a Canadian generic pharmaceutical company that has helped avert 15 national drug shortages on 10 different molecules since 2014. During the COVID-19 pandemic, they collaborated with the Government of Canada to supply 7.5 million doses of hydroxychloroquine[5].

Therapeutic areas: GastroenterologyCardiovascularNeurologyInfectious Diseases
Modalities: Small molecules
Industry: Biotech

Partnerships

Government of Canada (collaborated for hydroxychloroquine supply during COVID-19)

Beyond the preview

Go deeper on Mint Pharmaceuticals.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mint Pharmaceuticals.